board of directors

David Sinclair, PhD:   In 2014, David Sinclair was named by Time Magazine as one of the 100 most influential people in the world. The article cites Sinclair’s 2013 study in which he and his colleagues identified a cause of aging that is potentially reversible, noting that Sinclair’s work makes possible the idea of “living more years with a body that’s robust enough to make the most of them.”  His several seminal research papers in Nature, Cell and Science have been reported in most of the leading news media including The Wall Street Journal, New York Times, TIME, and Newsweek.

  • Professor in the Genetic Department at Harvard Medical School, Boston.
  • Co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging.
  • Professor at the School of Medicine at The University of New South Wales (UNSW), Sydney.
  • Co-founder and Co-chief Editor of the scientific journal Aging.
  • Co-founder Sirtris Pharmaceuticals (Cambridge, MA; NASDAQ:SIRT), Genocea Biosciences (Cambridge, MA; NASDAQ:GNCA), OvaScience (Cambridge, MA; NASDAQ:OVAS), Cohbar, BigDataBio and MetroBiotech.
  • Consultant for GlaxoSmithKline, InsideTracker, Metrobiotech, and Ovascience.

Awards, Fellowships and Scholarships

American Association for Aging Research Fellowship, Leukemia Society Fellowship, a Ludwig Scholarship, Ellison Medical Foundation Scholarships, Fisher Lectureship, The Australian Commonwealth Prize, a Helen Hay Whitney Postdoctoral Award, The Nathan Shock Award from NIH, Genzyme Outstanding Achievement in Biomedical Science Award, Telluride Technology Award, Innovator of the Year, MERIT Award from the NIA, Nathan Shock Award, The Merck Prize, a “Bio-Innovator Award”, Excellence in Teaching at Harvard Medical School, Denham Harman Research Award, ASMR Medal, Australian Society for Medical Research.

Sinclair obtained his Ph.D. in Molecular Genetics at the University of New South Wales, Sydney in 1995.

Andy Cunningham:  An entrepreneur at the forefront of marketing, branding, positioning and communicating “The Next Big Thing,” Andy is Founder and President of Cunningham Collective, a brand strategy firm dedicated to bringing game-changing technologies, innovations and companies to market.

  • Arrived in Silicon Valley in 1983 to work for Regis McKenna and help Steve Jobs launch the Macintosh.
  • When Jobs left Apple to form NeXT and acquire Pixar, he chose Andy’s public relations agency, Cunningham Communication, to represent him. She worked with Jobs for several  years.
  • Market expertise includes telecommunications, energy efficiency, media and publishing, finance, mobile apps, display technology, healthcare, big data and semiconductors.
  • Key player in launching new categories including video games; personal computers; desktop publishing; digital imaging; RISC microprocessors; software as a service; very light jets; and clean tech investing.

Corporate Boards, Institutional Boards and Non-Profits:

Specialized Bicycle Components, Inc., Finelite, Inc. (LED lighting systems) and RhythmOne, LLC (programmatic ad platform).

The Aspen Institute; Menlo College; Northwestern University Medill School of Journalism, Media, Integrated Marketing Communications; ZERO1: The Art & Technology Network, (she founded in 2000) with the mission to shape the future at the intersection of art and technology. Past board positions include YPO, WPO, CEO, the Peninsula Open Space Trust and the Computer History Museum.

Cunningham is an Aspen Institute Henry Crown Fellow and holds memberships in WPO, CEO, TED and Women Corporate Directors. In 2015, Andy founded DoubleX, a new initiative led by Cunningham Collective with the mission to make women in technology a fact, not an issue.

Northwestern University graduate and lives in Palo Alto, California with her aviator family:
her husband Rand Siegfried, and their two children, McKinley and Cormac.

Edward (Ed) F. Lange, Jr.:  30 years of executive leadership experience in the real estate finance, residential and healthcare industries.

Currently, Chief Financial Officer, Chief Operating Officer, and Treasurer for American Realty Capital Healthcare Advisors, managing two privately-owned healthcare REITs with aggregate assets of more than $2.0 billion.

Previous positions include:

  • Chief Executive Officer of HRC Investors Corp.
  • Chief Financial Officer and Director of Americold Realty Trust.
  • Chief Financial Officer, Chief Operating Officer and Director for 10 years, at BRE Properties, Inc. (NYSE: BRE), a New York Stock Exchange traded real estate investment trust.
  • Chief Financial Officer at Health Care REIT, Inc. (NYSE: HCN), a New York Stock Exchange traded REIT.
  • Senior Vice President of Finance of The Mediplex Group Inc., a publicly-owned operator and developer of skilled nursing facilities and rehabilitation hospitals.
  • Independent Director, STAG Industrial, Inc. (NYSE: STAG), a New York Stock Exchange traded REIT.
  • Independent Director, American Assets Trust, Inc. (NYSE: AAT), a New York Stock Exchange traded REIT.
  • He started his career in investment banking with The Advest Group Inc.

Advisory Board Member:

Anyone Home, Inc
Mr. Lange holds a Master of Business Administration degree from the University of Connecticut
and Bachelor of Science degree in Urban Planning from the University of Massachusetts